Wed.Feb 02, 2022

article thumbnail

Is it too late for Biogen?

World of DTC Marketing

Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. But is it too late for Biogen to stage a comeback with their reputation damaged? Biogen executives vowed to fight hard to reverse Medicare’s preliminary decision to sharply limit coverage of the company’s Alzheimer’s drug while saying more

article thumbnail

Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients

Clarify Health

Pfizer partnered with Clarify on an observational study on diagnostic testing patterns in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. This novel study is the first of its kind for ATTR-CM patients. In January 2022, the study titled, Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population, was published in the American Journal of Cardiology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 KNOW-HOWS FOR BECOMING A GOOD MEDICAL SALES REPRESENTATIVE

eMediWrite

You’ll be the vital link between medical and pharmaceutical firms and healthcare providers as a Medical Sales Representative. General practitioners (GPs), hospital doctors, pharmacists, practise managers, nurses, dentists, and veterinary surgeons are just a few of the people you’ll meet. You’ll position and differentiate your items – which might include prescription pharmaceuticals, drugstore or OTC brands, wound care, nutrition, diagnostics, or vaccines – from the

article thumbnail

Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients

Clarify Health

Pfizer partnered with Clarify on an observational study on diagnostic testing patterns in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. This novel study is the first of its kind for ATTR-CM patients. In January 2022, the study titled, Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population, was published [.].

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud